Technology · Information Technology Services
· website
· 1,142 employees
$1.25
52wk 0.65 – 1.98
Overall
46.6
Value
92.4
Growth
12.2
Health
74.4
Quality
0.0
Momentum
41.0
Dividend
—
Price
About Appen Limited
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application. The company serves technology, automotive, financial services, retail, government, and healthcare sectors. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Sydney, Australia.
Price analytics
Returns
1 day
7.3%
1 week
7.8%
1 month
21.4%
3 months
34.4%
6 months
-16.4%
1 year
41.2%
3 years
33.4%
Risk
Volatility (1y ann.)
96.1%
Beta vs ASX 200
2.58
Sharpe (1y)
0.79
VaR 95% (1-day)
-7.7%
Max drawdown (1y)
-56.8%
Off 1-year high
-34.2%
Technicals
RSI(14)
73
OB
vs 50DMA
3.5%
vs 200DMA
0.2%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value92.4
Trailing P/E
—
Forward P/E
94
PEG ratio
—
EV / EBITDA
100
Price / Book
75
Price / Sales
94
Growth12.2
Revenue growth (1y)
24
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health74.4
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
0
Current ratio
85
Debt / Equity
100
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum41.0
6-month return vs ASX 200
12
Price vs 200-day average
51
Price vs 50-day average
68
Position in 52-week range
45
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).